Figure 4
From: Ceramides are early responders in metabolic syndrome development in rhesus monkeys
Interactions among sphingolipid species and other circulating lipids. Correlations were calculated separately for control (Ctrl) and metabolically impaired (Meti) animals pre-diagnosis (pre-Dx) when all animals were classified as healthy and at time of diagnosis (Dx). Strong positive or negative correlations ( >|0.7|) are indicated by color according to the legend, blank spaces indicate correlations that fall below threshold ( <|0.7|) or species that fall below detection. (a) Left: ceramides against ceramides, middle: ceramides against diacylglycerols (DAG), right: ceramides against nonesterified fatty acids (NEFA). (b) Left: sphingomyelins against sphingomyelins (SM), middle: sphingomyelins against diacylglycerols (DAG), right: sphingomyelins against nonesterified fatty acids (NEFA). (DHCer: Dihydroceramide, HexCer: Hexosylceramide, LacCer: Lactosylceramide) n = 8 animals per group per time point.
